Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David S. Ege currently holds 77,575 shares of Seres Therapeutics, Inc. (MCRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David S. Ege has been a net seller of MCRB stock. They have purchased $0 and sold $89.1K worth of shares.
David S. Ege's most recent insider trade was on Aug 16, 2024, when they sold 1,128 shares at $0.84 per share.
David S. Ege serves as Executive at Seres Therapeutics, Inc. (MCRB). They have executed 19 insider transactions totaling $89.1K over their tenure at the company.
David S. Ege holds the position of Executive at Seres Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
David S. Ege has shown a selling trading pattern, with $0 in total purchases and $89.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David S. Ege was on Jul 5, 2022, when they purchased $100.0K worth of MCRB shares. This transaction involved 31,746 shares at $3.15 per share.
David S. Ege currently owns 77,575 shares of Seres Therapeutics, Inc. (MCRB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David S. Ege's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David S. Ege has 19 Form 4 filings on record as an insider at Seres Therapeutics, Inc..
Set alerts for David S. Ege and 40,000+ other insiders.